GenomeAI
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $190M
Overview
An AI-driven genomics company developing advanced diagnostic tools for precision medicine.
Genetics & GenomicsDiagnostics
Technology Platform
A proprietary AI and machine learning platform that analyzes genomic data to identify disease biomarkers and enable precision diagnostics.
Funding History
1Total raised:$190M
Series B$190M
Opportunities
Growing demand for personalized medicine and non-invasive diagnostics creates a large addressable market for AI-powered genomic solutions.
Risk Factors
Regulatory hurdles for AI/ML-based software as a medical device and data privacy concerns pose significant challenges.
Competitive Landscape
Faces competition from established genomic firms like Illumina's AI initiatives and startups such as Tempus and Freenome in the data-driven diagnostics space.